Bausch Health Companies (BHC) Change in Cash (2009 - 2026)
Bausch Health Companies (BHC) posted Change in Cash of $526.0 million for Q2 2026, up 4146.15% sequentially from -$13.0 million in Q1 2026, and down 10.24% YoY from $586.0 million in Q2 2025.
Bausch Health Companies (BHC) Change in Cash (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Change in Cash for 18 years, with the latest figure at $526.0 million in Q2 2026.
- Quarterly Change in Cash fell 10.24% year-over-year to $526.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $95.0 million (down 91.52% YoY) and the FY2025 annual result came in at $124.0 million, down 48.12% from the prior year.
- Change in Cash climbed to $526.0 million in Q2 2026 per BHC's latest filing, from -$13.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $586.0 million in Q2 2025 and troughed at -$1.4 billion in Q3 2022.
- A 5-year average of -$15.6 million and a median of $22.0 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2025: Change in Cash tumbled 9771.43% in 2022, then surged 543.94% in 2025.
- Over 5 years, Change in Cash stood at $94.0 million in 2022, then jumped by 93.62% to $182.0 million in 2023, then jumped by 147.8% to $451.0 million in 2024, then tumbled by 103.33% to -$15.0 million in 2025, then surged by 3606.67% to $526.0 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $526.0 million, -$13.0 million, and -$15.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | 526.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 526.00 Mn |
| Mar 31, 2026 | -13.00 Mn |
| Dec 31, 2025 | -15.00 Mn |
| Sep 30, 2025 | -403.00 Mn |
| Jun 30, 2025 | 586.00 Mn |
| Mar 31, 2025 | -44.00 Mn |
| Dec 31, 2024 | 451.00 Mn |
| Sep 30, 2024 | 127.00 Mn |
| Jun 30, 2024 | -132.00 Mn |
| Mar 31, 2024 | -207.00 Mn |
| Dec 31, 2023 | 182.00 Mn |
| Sep 30, 2023 | 192.00 Mn |
| Jun 30, 2023 | 57.00 Mn |
| Mar 31, 2023 | -60.00 Mn |
| Dec 31, 2022 | 94.00 Mn |
| Sep 30, 2022 | -1.38 Bn |
| Jun 30, 2022 | -581.00 Mn |
| Mar 31, 2022 | 341.00 Mn |
| Dec 31, 2021 | 215.00 Mn |
| Sep 30, 2021 | -14.00 Mn |